Skip to content

ImmuCell Corporation: 10-Q filed 2025-11-13

What ImmuCell Corporation reported in its quarterly report filed 2025-11-13 (fiscal Q3 2025): 51 published measures, 163 facts as tagged in accession 0001437749-25-034817.

This filing

Form
10-Q (quarterly report)
Filed
2025-11-13
Fiscal period
fiscal Q3 2025
Accession
0001437749-25-034817 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All ImmuCell Corporation filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2025-09-3045,730,123USD
At 2024-12-3145,100,477USD
At 2024-09-3044,448,873USD
At 2023-12-3143,808,102USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2025-09-3015,929,282USD
At 2024-12-3117,582,290USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2025-09-3029,800,841USD
At 2025-06-3029,867,428USD
At 2024-12-3127,518,187USD
At 2024-09-3026,411,671USD
At 2024-06-3023,455,463USD
At 2023-12-3124,993,077USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2025-09-303,886,198USD
At 2024-12-313,758,232USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2025-07-01 to 2025-09-30-139,748USD92
2025-01-01 to 2025-09-301,809,115USD273
2024-07-01 to 2024-09-30-701,690USD92
2024-01-01 to 2024-09-30-2,671,184USD274

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2025-01-01 to 2025-09-301,992,751USD273
2024-01-01 to 2024-09-30360,954USD274

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2025-01-01 to 2025-09-301,078,133USD273
2024-01-01 to 2024-09-30269,509USD274

Contract revenue excluding tax

Revenue from customer contracts excluding assessed taxes under this specific taxonomy concept. It is not automatically comparable to older revenue tags.

PeriodValueUnitDays
2025-07-01 to 2025-09-305,506,122USD92
2025-01-01 to 2025-09-3020,018,175USD273
2024-01-01 to 2024-12-3126,493,169USD366
2024-07-01 to 2024-09-306,011,573USD92
2024-01-01 to 2024-09-3018,742,040USD274
2023-01-01 to 2023-09-3017,471,669USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2025-01-01 to 2025-09-30-817,784USD273
2024-01-01 to 2024-09-302,733,947USD274

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2025-01-01 to 2025-09-30-1,047,001USD273
2024-01-01 to 2024-09-30-265,009USD274

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2025-09-30-12,354,611USD
At 2024-12-31-14,163,726USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2025-07-01 to 2025-09-309,045,851shares92
2025-01-01 to 2025-09-309,019,484shares273
2024-07-01 to 2024-09-308,164,423shares92
2024-01-01 to 2024-09-307,908,425shares274

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2025-07-01 to 2025-09-309,045,851shares92
2025-01-01 to 2025-09-309,019,484shares273
2024-07-01 to 2024-09-308,164,423shares92
2024-01-01 to 2024-09-307,908,425shares274

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2025-07-01 to 2025-09-30-0.02USD/shares92
2025-01-01 to 2025-09-300.2USD/shares273
2024-07-01 to 2024-09-30-0.09USD/shares92
2024-01-01 to 2024-09-30-0.34USD/shares274

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2025-07-01 to 2025-09-30-0.02USD/shares92
2025-01-01 to 2025-09-300.2USD/shares273
2024-07-01 to 2024-09-30-0.09USD/shares92
2024-01-01 to 2024-09-30-0.34USD/shares274

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2025-07-01 to 2025-09-304,456USD92
2025-01-01 to 2025-09-308,264USD273
2024-07-01 to 2024-09-301,340USD92
2024-01-01 to 2024-09-304,020USD274

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2025-09-3024,340,740USD
At 2024-12-3125,349,019USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2025-01-01 to 2025-09-30192,090USD273
2024-01-01 to 2024-09-30256,688USD274

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2025-07-01 to 2025-09-3020,075USD92
2025-01-01 to 2025-09-301,707,261USD273
2024-01-01 to 2024-12-31-1,640,159USD366
2024-07-01 to 2024-09-30-574,894USD92
2024-01-01 to 2024-09-30-2,261,554USD274
2023-01-01 to 2023-09-30-5,748,078USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2025-09-3016,825,178USD
At 2024-12-3115,042,750USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2025-09-303,997,888USD
At 2024-12-314,412,213USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

PeriodValueUnitDays
At 2025-09-3095,557USD
At 2024-12-3195,557USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2025-09-304,776USD
At 2024-12-3119,104USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2025-09-302,554,766USD
At 2024-12-313,771,133USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2025-07-01 to 2025-09-302,343,023USD92
2025-01-01 to 2025-09-306,827,733USD273
2024-01-01 to 2024-12-319,581,203USD366
2024-07-01 to 2024-09-302,158,448USD92
2024-01-01 to 2024-09-307,370,952USD274
2023-01-01 to 2023-09-309,617,362USD273

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2025-09-309,802,005USD
At 2024-12-317,112,623USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2025-07-01 to 2025-09-302,363,098USD92
2025-01-01 to 2025-09-308,534,994USD273
2024-01-01 to 2024-12-317,941,044USD366
2024-07-01 to 2024-09-301,583,554USD92
2024-01-01 to 2024-09-305,109,398USD274
2023-01-01 to 2023-09-303,869,284USD273

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2025-07-01 to 2025-09-303,143,024USD92
2025-01-01 to 2025-09-3011,483,181USD273
2024-01-01 to 2024-12-3118,552,125USD366
2024-07-01 to 2024-09-304,428,019USD92
2024-01-01 to 2024-09-3013,632,642USD274
2023-01-01 to 2023-09-3013,602,385USD273

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2025-07-01 to 2025-09-30694,311USD92
2025-01-01 to 2025-09-302,283,016USD273
2024-01-01 to 2024-12-313,898,582USD366
2024-07-01 to 2024-09-30786,136USD92
2024-01-01 to 2024-09-303,079,189USD274
2023-01-01 to 2023-09-304,394,852USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2025-09-309,045,851shares
At 2024-12-318,979,091shares

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2025-09-304,419,527USD
At 2024-12-314,560,679USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

PeriodValueUnitDays
At 2025-09-304,115,122USD
At 2024-12-314,561,174USD

Long-term debt

Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.

PeriodValueUnitDays
At 2025-09-309,490,550USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2025-09-3045,939,840USD
At 2024-12-3146,390,570USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2025-09-3021,599,100USD
At 2024-12-3121,041,551USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2025-09-3044,345USD
At 2024-12-3133,368USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2025-09-30582,209USD
At 2024-12-31400,762USD

Net deferred tax assets

Deferred tax assets after the valuation allowance. Realization depends on future taxable income, so the balance is not a receivable from tax authorities.

PeriodValueUnitDays
At 2025-09-300USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2025-07-01 to 2025-09-30-135,292USD92
2025-01-01 to 2025-09-301,817,379USD273
2024-07-01 to 2024-09-30-700,350USD92
2024-01-01 to 2024-09-30-2,667,164USD274

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2025-07-01 to 2025-09-30729,421USD92
2025-01-01 to 2025-09-302,072,682USD273
2024-01-01 to 2024-12-312,216,549USD366
2024-07-01 to 2024-09-30528,267USD92
2024-01-01 to 2024-09-301,661,838USD274
2023-01-01 to 2023-09-302,134,295USD273

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2025-07-01 to 2025-09-30674,314USD92
2025-01-01 to 2025-09-302,008,958USD273
2024-07-01 to 2024-09-30670,346USD92
2024-01-01 to 2024-09-301,999,005USD274

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2025-07-01 to 2025-09-30708,667USD92
2025-01-01 to 2025-09-302,074,477USD273
2024-01-01 to 2024-12-312,729,847USD366
2024-07-01 to 2024-09-30685,927USD92
2024-01-01 to 2024-09-302,045,192USD274
2023-01-01 to 2023-12-312,739,620USD365

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2025-07-01 to 2025-09-304,776USD92
2025-01-01 to 2025-09-3014,328USD273
2024-07-01 to 2024-09-304,776USD92
2024-01-01 to 2024-09-3014,328USD274

Nonoperating interest expense

Interest expense presented outside operating results. It differs from total interest expense when some borrowing cost is classified as operating or capitalized.

PeriodValueUnitDays
2025-07-01 to 2025-09-30134,516USD92
2025-01-01 to 2025-09-30387,239USD273
2024-07-01 to 2024-09-30144,141USD92
2024-01-01 to 2024-09-30432,529USD274

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2025-07-01 to 2025-09-30-155,367USD92
2025-01-01 to 2025-09-30110,118USD273
2024-07-01 to 2024-09-30-125,456USD92
2024-01-01 to 2024-09-30-405,610USD274

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2025-01-01 to 2025-09-30340,381USD273
2024-01-01 to 2024-09-30404,077USD274

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

PeriodValueUnitDays
2025-01-01 to 2025-09-3010,205USD273
2024-01-01 to 2024-09-305,905USD274

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2025-01-01 to 2025-09-30349,326USD273
2024-01-01 to 2024-09-304,108,730USD274
2016-02-01 to 2021-04-3026,714,403USD1916

Operating lease payments

Cash paid for operating lease liabilities during the period. It differs from lease expense recognized and excludes variable payments in some presentations.

PeriodValueUnitDays
2025-07-01 to 2025-09-30334,744USD92
2025-01-01 to 2025-09-30603,374USD273
2024-07-01 to 2024-09-30144,315USD92
2024-01-01 to 2024-09-30432,945USD274

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2025-01-01 to 2025-09-30-1,216,367USD273
2024-01-01 to 2024-09-30122,530USD274

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2025-01-01 to 2025-09-302,689,382USD273
2024-01-01 to 2024-09-30-351,389USD274

Inspect the source

Entity
ImmuCell Corporation / CIK 0000811641
Captured
2026-09-19T15:06:16.277Z
SEC response SHA-256
e6fd54c346f29af23b63003a8b733aa2d9275cd6689854dc3a6eebcd0ca809e7

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000811641.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))